Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Getty Pictures through TBE / ISTOCE Editorial
- Novartis (NYSE:Nvs) Oral Fabhalta (IPTacopan), US food and drug management, along with C3 Glomerulopathy, approved the first and only treatment approved for this situation to reduce proteinuria.
- Phase III
